Technetium-99m tetrofosmin uptake in insular thyroid carcinoma - A comparison with iodine-131

Degirmenci B., Aydin A., Comlekci A., Ozdogan Ö., BEKİŞ R.

CLINICAL NUCLEAR MEDICINE, cilt.28, sa.5, ss.385-388, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 5
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1097/00003072-200305000-00004
  • Dergi Adı: CLINICAL NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.385-388
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

The authors describe a 42-year-old man with insular thyroid carcinoma. In this patient, iodine-131 (I-131) and technetium-99m (Tc-99m) tetrofosmin imaging were performed to investigate residual thyroid tissue and metastatic foci of tumor. Both I-131 and Tc-99m tetrofosmin images showed metastatic foci, but Tc-99m tetrofosmin imaging revealed the lesions better than did the I-131 scan. Tc-99m tetrofosmin imaging does not require withholding of thyroid hormone suppression and can be used for follow-up evaluation of patients with insular thyroid carcinoma.